Oslo Business Memo



[press release] AMERRA enters Norwegian marine ingredient industry: Integrates Marine Bioproducts and Alkymar.


From left: Thor Talseth, Amerra, Jan Arne Vevatne, Biomega, Kjartan Sandnes, Alkymar. Collage: BFM

From left: Thor Talseth, Amerra, Jan Arne Vevatne, Biomega, Kjartan Sandnes, Alkymar. Collage: BFM


(New York, Bergen-Norway) AMERRA Capital Management, LLC (“AMERRA”), a New York based agribusiness asset manager, today announced that it has acquired more than 90% of Marine Bioproducts/Biomega (“Biomega”) based in Sotra, Norway.  Biomega is the leading producer of high quality human grade peptones, proteins and oils derived from fresh fish by-products. Biomega collaborates with Alkymar, a provider of industrial enzymatic hydrolysis solutions with complementary technology and expertise.  AMERRA intends to integrate the two companies. 

Biomega was founded in 2001 with the purpose of conserving the nutritional value of by-products from the salmon farming industry.  While these by-products were historically destined for lower grade animal feed, Biomega has developed technology applications for the premium pet foods and human nutrition market segments. 

Alkymar was founded in 2014 as a solutions provider of hydrolysis technology.  Equipped with strong nutrition, biology and industrial engineering skills, the Alkymar team has not only developed complementary intellecutal property to Biomega, but also established partnerships beyond the seafood sector, utilizing hydrolosis techonology in adjacent markets such as the poultry industry. 

AMERRA was attracted by the inherent value and skills embedded in both companies and believes the combination will drive innovation and growth. 

Jan Arne Vevatne, Managing Director of Biomega, commented, “We are excited to partner with AMERRA given their deep knowledge of the global seafood and agriculture space.  As Biomega pursues growth in higher value added products, we are delighted to deepen our collaboration with the Alkymar team given their unique combination of nutrition knowledge and industrial hydrolysis skills.”

Thor Talseth, Managing Director at AMERRA said, “A fully automated human grade production process has enabled Biomega to produce a suite of high value products in a cost efficient way. Combined with Alkymar’s deep competence and AMERRA’s global reach, we will have a strong foundation to build a successful international business based on world leading Norwegian technology.   We look forward to supporting the business in driving efficiencies, taking advantage of expansion opportunities and teaming up with exceptional teams.”

Kjartan Sandnes, Managing Director of Alkymar, added, “As a founder of Biomega, I am pleased to fully join forces with my friends and former colleagues, now with the opportunity to realize the global potential of our combined resources. Our technology preserves the nutritional value of the raw material and maximizes the combined value in a unique way. We are excited to leverage AMERRA’s agriculture knowledge and network and expand outside of Norway.”

  • About AMERRA Capital Management, LLC

AMERRA Capital Management, LLC is a New York based agribusiness asset manager with over $1.8 billion in AUM.  AMERRA deploys capital supporting growth-oriented agribusinesses around the world and seeks to add value as a supportive and active partner with a full spectrum of customized equity and debt capital strategies.  Since its inception in 2009, AMERRA has completed over 250 investments with an aggregate value in excess of $3.4 billion.


MEDIA CONTACT for AMERRA Capital Management, LLC: 

  • David Gould dgould@amerracapital.com